Q15678 (PTN14_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Tyrosine-protein phosphatase non-receptor type 14 EC=3.1.3.48 Alternative name(s): Protein-tyrosine phosphatase pez | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1187 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Protein tyrosine phosphatase which may play a role in the regulation of lymphangiogenesis, cell-cell adhesion, cell-matrix adhesion, cell migration, cell growth and also regulates TGF-beta gene expression, thereby modulating epithelial-mesenchymal transition. Mediates beta-catenin dephosphorylation at adhesion junctions. Acts as a negative regulator of the oncogenic property of YAP, a downstream target of the hippo pathway, in a cell density-dependent manner. May function as a tumor suppressor. Ref.5 Ref.6 Ref.7 Ref.10 Ref.12 Ref.13 Ref.14 |
| Catalytic activity | Protein tyrosine phosphate + H2O = protein tyrosine + phosphate. |
| Subunit structure | Interacts with FLT4; the interaction is enhanced by stimulation with VEGFC. Interacts (via PPxY motifs) with YAP1 (via WW domains); this interaction leads to the cytoplasmic sequestration of YAP1 and inhibits its transcriptional co-activator activity. Ref.10 Ref.12 Ref.14 |
| Subcellular location | Cytoplasm. Cytoplasm › cytoskeleton By similarity. Nucleus. Note: Translocation into the nucleus is associated with induction of cell proliferation. Partially colocalized with actin filaments at the plasma membrane. Ref.5 Ref.12 |
| Tissue specificity | Ubiquitous. |
| Induction | Up-regulated at protein level by cell density. However, at the mRNA level remains the same regardless of the status of cell density. Ref.12 |
| Post-translational modification | Ubiquitinated by the ECS (Elongin BC-CUL2/5-SOCS-box protein)/LRR1 E3 ligase complex and subsequently targeted to proteasomal degradation. Ref.12 |
| Involvement in disease | Choanal atresia and lymphedema (CHATLY) [MIM:613611]: A disease characterized by posterior choanal atresia and lymphedema. Additional features are a high-arched palate, hypoplastic nipples, and mild pectus excavatum. Influence clinical severity of hereditary haemorragic telagiectasia (HHT). Frequently mutated in a variety of human cancers (PubMed:15155950). |
| Sequence similarities | Belongs to the protein-tyrosine phosphatase family. Non-receptor class subfamily. Contains 1 FERM domain. Contains 1 tyrosine-protein phosphatase domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1187 | 1187 | Tyrosine-protein phosphatase non-receptor type 14 | PRO_0000219437 | ||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 21 – 306 | 286 | FERM | |||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 909 – 1180 | 272 | Tyrosine-protein phosphatase | |||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 1121 – 1127 | 7 | Substrate By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 1121 – 1127 | 7 | Substrate binding By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 566 – 573 | 8 | Poly-Pro | |||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 709 – 716 | 8 | Poly-Glu | |||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 1121 | 1 | Phosphocysteine intermediate By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 1079 | 1 | Substrate By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 1165 | 1 | Substrate By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 486 | 1 | Phosphoserine Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 591 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 593 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 594 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 642 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 159 | 1 | Q → E in a breast cancer sample; somatic mutation. Ref.16 | VAR_035849 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 360 | 1 | H → P in a breast cancer sample; somatic mutation. Ref.16 | VAR_035850 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 505 | 1 | V → F. Corresponds to variant rs12239356 [ dbSNP | Ensembl ]. | VAR_046995 | ||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 392 | 1 | H → D in CAA57993. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 896 – 903 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 909 – 914 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 926 – 929 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 931 – 933 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 946 – 948 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 964 – 972 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 975 – 982 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 987 – 989 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 990 – 999 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1004 – 1007 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1011 – 1013 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1032 – 1035 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1038 – 1047 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1049 – 1060 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 1061 – 1063 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1066 – 1074 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1079 – 1081 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1086 – 1103 | 18 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1105 – 1107 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1117 – 1125 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1126 – 1142 | 17 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1149 – 1157 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1167 – 1183 | 17 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Pez: a novel human cDNA encoding protein tyrosine phosphatase- and ezrin-like domains." Smith A.L., Mitchell P.J., Shipley J., Gusterson B.A., Rogers M.V., Crompton M.R. Biochem. Biophys. Res. Commun. 209:959-965(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Mammary carcinoma. |
| [2] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Heart and Lung. |
| [5] | "Translocation of protein tyrosine phosphatase Pez/PTPD2/PTP36 to the nucleus is associated with induction of cell proliferation." Wadham C., Gamble J.R., Vadas M.A., Khew-Goodall Y. J. Cell Sci. 113:3117-3123(2000) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, FUNCTION. |
| [6] | "The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin." Wadham C., Gamble J.R., Vadas M.A., Khew-Goodall Y. Mol. Biol. Cell 14:2520-2529(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [7] | "The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development." Wyatt L., Wadham C., Crocker L.A., Lardelli M., Khew-Goodall Y. J. Cell Biol. 178:1223-1235(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [8] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [9] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [10] | "Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans." Au A.C., Hernandez P.A., Lieber E., Nadroo A.M., Shen Y.M., Kelley K.A., Gelb B.D., Diaz G.A. Am. J. Hum. Genet. 87:436-444(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH FLT4, INVOLVEMENT IN CHATLY. |
| [11] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-591; SER-594 AND SER-642, MASS SPECTROMETRY. |
| [12] | "PTPN14 is required for the density-dependent control of YAP1." Wang W., Huang J., Wang X., Yuan J., Li X., Feng L., Park J.I., Chen J. Genes Dev. 26:1959-1971(2012) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, INDUCTION, FUNCTION, INTERACTION WITH YAP1; CUL2 AND LRR1, UBIQUITINATION. |
| [13] | "Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia." Benzinou M., Clermont F.F., Letteboer T.G., Kim J.H., Espejel S., Harradine K.A., Arbelaez J., Luu M.T., Roy R., Quigley D., Higgins M.N., Zaid M., Aouizerat B.E., van Amstel J.K., Giraud S., Dupuis-Girod S., Lesca G., Plauchu H. Akhurst R.J.Nat. Commun. 3:616-616(2012) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN HEREDITARY HAEMORRAGIC TELAGIECTASIA, FUNCTION. |
| [14] | "PTPN14 interacts with and negatively regulates the oncogenic function of YAP." Liu X., Yang N., Figel S.A., Wilson K.E., Morrison C.D., Gelman I.H., Zhang J. Oncogene 32:1266-1273(2013) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH YAP1, FUNCTION, MASS SPECTROMETRY. |
| [15] | "Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution." Barr A.J., Debreczeni J.E., Eswaran J., Knapp S. Proteins 63:1132-1136(2006) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 886-1187. |
| [16] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] GLU-159 AND PRO-360. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X82676 mRNA. Translation: CAA57993.1. AL929236 AL603838 Genomic DNA. Translation: CAH70919.1.AL603838 AL929236 Genomic DNA. Translation: CAH72982.1.AL445305 AL929236 Genomic DNA. Translation: CAH73027.1.AL592216 AL929236 Genomic DNA. Translation: CAH73479.1.CH471100 Genomic DNA. Translation: EAW93351.1. BC101754 mRNA. Translation: AAI01755.1. BC104803 mRNA. Translation: AAI04804.1. | ||||||||||||
| IPI | IPI00018914. | ||||||||||||
| PIR | JC4155. | ||||||||||||
| RefSeq | NP_005392.2. NM_005401.4. | ||||||||||||
| UniGene | Hs.193557. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q15678. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q15678. 2 interactions. | ||||||||||||
| STRING | 9606.ENSP00000355923. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q15678. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 209572662. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q15678. | ||||||||||||
| PRIDE | Q15678. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 5784. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000366956; ENSP00000355923; ENSG00000152104. | ||||||||||||
| GeneID | 5784. | ||||||||||||
| KEGG | hsa:5784. | ||||||||||||
| UCSC | uc001hkk.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 5784. | ||||||||||||
| GeneCards | GC01M214523. | ||||||||||||
| HGNC | HGNC:9647. PTPN14. | ||||||||||||
| HPA | CAB011469. | ||||||||||||
| MIM | 603155. gene. 613611. phenotype. | ||||||||||||
| neXtProt | NX_Q15678. | ||||||||||||
| PharmGKB | PA33989. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5599. | ||||||||||||
| HOGENOM | HOG000115775. | ||||||||||||
| HOVERGEN | HBG053757. | ||||||||||||
| InParanoid | Q15678. | ||||||||||||
| KO | K01104. | ||||||||||||
| OMA | TTKFRTD. | ||||||||||||
| OrthoDB | EOG4320X9. | ||||||||||||
| PhylomeDB | Q15678. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q15678. | ||||||||||||
| Bgee | Q15678. | ||||||||||||
| CleanEx | HS_PTPN14. | ||||||||||||
| Genevestigator | Q15678. | ||||||||||||
| GermOnline | ENSG00000152104. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.20.80.10. 1 hit. 2.30.29.30. 1 hit. | ||||||||||||
| InterPro | IPR019749. Band_41_domain. IPR019750. Band_41_fam. IPR014352. FERM/acyl-CoA-bd_prot_3-hlx. IPR019748. FERM_central. IPR019747. FERM_CS. IPR000299. FERM_domain. IPR018979. FERM_N. IPR018980. FERM_PH-like_C. IPR011993. PH_like_dom. IPR000387. Tyr/Dual-sp_Pase. IPR016130. Tyr_Pase_AS. IPR014392. Tyr_Pase_non-rcpt_typ-14/21. IPR000242. Tyr_Pase_rcpt/non-rcpt. [Graphical view] | ||||||||||||
| Pfam | PF09380. FERM_C. 1 hit. PF00373. FERM_M. 1 hit. PF09379. FERM_N. 1 hit. PF00102. Y_phosphatase. 1 hit. [Graphical view] | ||||||||||||
| PIRSF | PIRSF000934. Tyr-Ptase_nr14. 1 hit. | ||||||||||||
| PRINTS | PR00935. BAND41. PR00700. PRTYPHPHTASE. | ||||||||||||
| SMART | SM00295. B41. 1 hit. SM00194. PTPc. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF47031. FERM_3-hlx. 1 hit. | ||||||||||||
| PROSITE | PS00660. FERM_1. 1 hit. PS00661. FERM_2. 1 hit. PS50057. FERM_3. 1 hit. PS00383. TYR_PHOSPHATASE_1. 1 hit. PS50056. TYR_PHOSPHATASE_2. 1 hit. PS50055. TYR_PHOSPHATASE_PTP. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | PTPN14. human. | ||||||||||||
| EvolutionaryTrace | Q15678. | ||||||||||||
| GenomeRNAi | 5784. | ||||||||||||
| NextBio | 22502. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | PTN14_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q15678 Secondary accession number(s): Q5VSI0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
